|
시장보고서
상품코드
1762264
세포 치료 기술 시장 규모, 점유율, 동향, 산업 분석 보고서 : 치료 유형별, 기술별, 용도별, 지역별 - 시장 예측(2025-2034년)Cell Therapy Technologies Market Size, Share, Trends, Industry Analysis Report: By Therapy Type, Technology, Application, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 세포 치료 기술 시장 규모는 2034년까지 444억 3,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
세포 치료 기술은 다양한 질병 치료를 위한 세포 기반 치료제를 개발, 제조, 제공하는 데 사용되는 도구, 기기, 시스템을 포괄합니다. 이러한 기술은 치료용 세포의 생존성과 기능성을 보장하기 위해 세포의 분리, 확대, 변형, 보존 등의 주요 과정을 지원합니다. 이러한 기술은 재생의료, 면역치료, 줄기세포 연구에 널리 활용되어 암, 신경질환, 심혈관질환, 자가면역질환 등의 치료에 도움을 주고 있습니다. 유전자 편집, 바이오프로세싱, 동결보존 등 치료기술의 발전으로 세포 치료 기술은 세포기반 치료의 안전성, 확장성, 유효성을 높이는데 매우 중요한 역할을 하고 있습니다.
세포 치료 기술 시장의 확대는 재생 의학 연구의 증가와 혁신적인 치료 옵션에 대한 수요 증가에 의해 이루어지고 있습니다. 이 시장은 자동화, 바이오리액터 기술, 유전체 편집 도구의 발전으로 제조 공정이 간소화되고 치료 결과가 개선되면서 성장하고 있습니다. 생명공학 기업 및 의료기관의 투자 증가와 함께 세포 기반 치료에 대한 규제적 지원은 시장 성장을 더욱 촉진하고 있습니다. 또한, 연구기관과 산업계와의 공동 연구는 기술 개발을 가속화하고 세포 치료 솔루션에 대한 폭넓은 접근성을 보장하고 있습니다. 맞춤형 의료가 가속화됨에 따라 효율적이고 확장성이 높은 세포 치료 기술에 대한 수요가 증가하여 현대 의료의 미래를 형성할 것으로 예상됩니다.
세포 치료 기술 시장 보고서 하이라이트
치료법 유형별로는 면역거부반응의 위험이 낮고, 맞춤형 의료에 대한 채택이 증가함에 따라 자가세포 치료 분야가 세포 치료 기술 시장에서 큰 비중을 차지하고 있습니다. 이러한 치료법은 재생의료 및 암 치료에 널리 사용되고 있으며, 시장에서의 우위에 기여하고 있습니다.
기술별로는 바이러스 벡터 기술 분야가 시장을 주도하고 있습니다. 바이러스 벡터는 정확한 유전자 변형을 가능하게함으로써 유전자 치료 및 세포 치료의 적용에 중요한 역할을 하고 있으며, CAR-T 세포 치료와 같은 첨단 치료법 개발에 널리 사용되고 있어 광범위한 채택과 높은 시장 수요를 보장하고 있습니다.
용도별로는 암의 유병률 증가와 세포 기반 면역 치료의 채택이 증가함에 따라 2024년에는 암 분야가 지배적인 부문으로 부상할 것으로 예상됩니다. 암 분야에서 세포 치료제 승인 건수가 증가함에 따라 이 시장에서의 입지가 강화되고 있습니다.
지역별로는 북미가 세포 치료 기술 시장 매출에서 가장 큰 비중을 차지하고 있습니다. 이는 이 지역의 높은 수준의 의료 인프라, 연구개발에 대한 막대한 투자, 우호적인 규제 환경 등에 기인한 것으로 분석됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 세포 치료 기술 시장 인사이트
- 시장 현황
- 세포 치료 기술 시장 역학
- 성장 촉진요인과 기회
- 정부 자금과 지원 증강
- 유전자 편집 기술의 진보
- 성장 억제요인과 과제
- 복잡한 규제 승인 프로세스
- 성장 촉진요인과 기회
- PESTEL 분석
- 세포 치료 기술 시장 애플리케이션 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 세포 치료 기술 시장 : 치료 유형별
- 주요 조사 결과
- 소개
- 동종요법
- 자가이식 요법
제6장 세계의 세포 치료 기술 시장 : 기술별
- 주요 조사 결과
- 소개
- 체세포 기술
- 세포 불멸화 기술
- 바이러스 벡터 기술
- 유전체 편집 기술
- 세포 가역성 기술
제7장 세계의 세포 치료 기술 시장 : 용도별
- 주요 조사 결과
- 소개
- 근골격
- 심혈관계
- 위장
- 신경학적
- 종양학
- 피부과
- 상처와 부상
- 안과
- 기타
제8장 세계의 세포 치료 기술 시장 : 지역별
- 주요 조사 결과
- 소개
- 세포 치료 기술 시장 분석 : 지역별, 2020-2034년
- 북미
- 북미 : 치료 유형별, 2020-2034년
- 북미 : 기술별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 치료 유형별, 2020-2034년
- 유럽 : 기술별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 치료 유형별, 2020-2034년
- 아시아태평양 : 기술별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 치료 유형별, 2020-2034년
- 중동 및 아프리카 : 기술별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 치료 유형별, 2020-2034년
- 라틴아메리카 : 기술별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Agilent Technologies Inc.
- Avantor, Inc.
- Becton, Dickinson and Company(BD)
- Bio-Techne Corporation
- Corning Incorporated
- Danaher Corporation
- Fresenius SE & Co. KGaA
- Lonza Group AG
- Merck KGaA
- Sartorius AG
- Terumo Corporation
- Thermo Fisher Scientific Inc
The global cell therapy technologies market size is expected to reach USD 44.43 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Therapy Technologies Market Size, Share, Trends, Industry Analysis Report: By Therapy Type (Allogeneic Therapies and Autologous Therapies), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Cell therapy technologies encompass the tools, equipment, and systems used to develop, manufacture, and deliver cell-based therapies for treating various diseases. These technologies support key processes such as cell isolation, expansion, modification, and preservation to ensure the viability and functionality of therapeutic cells. They are widely utilized in regenerative medicine, immunotherapy, and stem cell research, aiding in the treatment of conditions such as cancer, neurological disorders, cardiovascular diseases, and autoimmune disorders. With advancements in gene editing, bioprocessing, and cryopreservation, cell therapy technologies continue to play a pivotal role in enhancing the safety, scalability, and efficacy of cell-based treatments.
The cell therapy technologies market expansion is driven by increasing research in regenerative medicine and the rising demand for innovative treatment options. The market benefits from advancements in automation, bioreactor technology, and genome editing tools that streamline manufacturing processes and improve therapeutic outcomes. Regulatory support for cell-based therapies, along with growing investments from biotechnology firms and healthcare institutions, is further fueling market growth. Additionally, collaborations between research organizations and industry players are accelerating technological developments, ensuring wider accessibility of cell therapy solutions. As personalized medicine gains momentum, the demand for efficient and scalable cell therapy technologies is expected to rise, shaping the future of modern healthcare.
Cell Therapy Technologies Market Report Highlights
By therapy type, the autologous therapies segment holds a larger cell therapy technologies market share due to their lower risk of immune rejection and increasing adoption in personalized medicine. These therapies are widely used in regenerative medicine and oncology treatments, contributing to their dominance in the market.
By technology, the viral vector technology segment leads the market, as it plays a crucial role in gene and cell therapy applications by enabling precise genetic modifications. Its established use in developing advanced therapies, such as CAR-T cell therapy, ensures its widespread adoption and high market demand.
By application, oncology was the dominant segment in 2024 due to the rising prevalence of cancer and the growing adoption of cell-based immunotherapies. The increasing number of regulatory approvals for cell therapy products in oncology has strengthened its position in the market.
By region, North America holds the largest share of the cell therapy technologies market revenue. This is attributed to the region's advanced healthcare infrastructure, substantial investments in research and development, and a supportive regulatory environment.
The cell therapy technologies market features several prominent companies actively contributing to its advancement. A few key players include Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Lonza Group AG; Sartorius AG; Agilent Technologies Inc.; Avantor, Inc.; Bio-Techne Corporation; Fresenius SE & Co. KGaA; Becton, Dickinson and Company (BD); Corning Incorporated; and Terumo Corporation.
Polaris Market Research has segmented the Cell Therapy Technologies market report on the basis of therapy type, technology, application, and region:
By Therapy Type Outlook (Revenue - USD Billion, 2020-2034)
Allogeneic Therapies
Autologous Therapies
By Technology Outlook (Revenue - USD Billion, 2020-2034)
Somatic Cell Technology
Cell Immortalization Technology
Viral Vector Technology
Genome Editing Technology
Cell Plasticity Technology
By Application Outlook (Revenue - USD Billion, 2020-2034)
Musculoskeletal
Cardiovascular
Gastrointestinal
Neurological
Oncology
Dermatology
Wound and Injuries
Ocular
Others
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Cell Therapy Technologies Market Insights
- 4.1. Cell Therapy Technologies Market - Market Snapshot
- 4.2. Cell Therapy Technologies Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Government Funding and Support
- 4.2.1.2. Advancements in Gene Editing Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Complex regulatory approval process
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cell Therapy Technologies Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Cell Therapy Technologies Market, by Therapy Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 5.3. Allogeneic Therapies
- 5.3.1. Global Cell Therapy Technologies Market, by Allogeneic Therapies, by Region, 2020-2034 (USD Billion)
- 5.4. Autologous Therapies
- 5.4.1. Global Cell Therapy Technologies Market, by Autologous Therapies, by Region, 2020-2034 (USD Billion)
6. Global Cell Therapy Technologies Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 6.3. Somatic Cell Technology
- 6.3.1. Global Cell Therapy Technologies Market, by Somatic Cell Technology, by Region, 2020-2034 (USD Billion)
- 6.4. Cell Immortalization Technology
- 6.4.1. Global Cell Therapy Technologies Market, by Cell Immortalization Technology, by Region, 2020-2034 (USD Billion)
- 6.5. Viral Vector Technology
- 6.5.1. Global Cell Therapy Technologies Market, by Viral Vector Technology, by Region, 2020-2034 (USD Billion)
- 6.6. Genome Editing Technology
- 6.6.1. Global Cell Therapy Technologies Market, by Genome Editing Technology, by Region, 2020-2034 (USD Billion)
- 6.7. Cell Plasticity Technology
- 6.7.1. Global Cell Therapy Technologies Market, by Cell Plasticity Technology, by Region, 2020-2034 (USD Billion)
7. Global Cell Therapy Technologies Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 7.3. Musculoskeletal
- 7.3.1. Global Cell Therapy Technologies Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
- 7.4. Cardiovascular
- 7.4.1. Global Cell Therapy Technologies Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
- 7.5. Gastrointestinal
- 7.5.1. Global Cell Therapy Technologies Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
- 7.6. Neurological
- 7.6.1. Global Cell Therapy Technologies Market, by Neurological, by Region, 2020-2034 (USD Billion)
- 7.7. Oncology
- 7.7.1. Global Cell Therapy Technologies Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 7.8. Dermatology
- 7.8.1. Global Cell Therapy Technologies Market, by Dermatology, by Region, 2020-2034 (USD Billion)
- 7.9. Wound and Injuries
- 7.9.1. Global Cell Therapy Technologies Market, by Wound and Injuries, by Region, 2020-2034 (USD Billion)
- 7.10. Ocular
- 7.10.1. Global Cell Therapy Technologies Market, by Ocular, by Region, 2020-2034 (USD Billion)
- 7.11. Others
- 7.11.1. Global Cell Therapy Technologies Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Cell Therapy Technologies Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Cell Therapy Technologies Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Cell Therapy Technologies Market - North America
- 8.3.1. North America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.3.3. North America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.3.4. Cell Therapy Technologies Market - U.S.
- 8.3.4.1. U.S.: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.3.5. Cell Therapy Technologies Market - Canada
- 8.3.5.1. Canada: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4. Cell Therapy Technologies Market - Europe
- 8.4.1. Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.3. Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.4. Cell Therapy Technologies Market - UK
- 8.4.4.1. UK: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.5. Cell Therapy Technologies Market - France
- 8.4.5.1. France: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.5.3. France: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.6. Cell Therapy Technologies Market - Germany
- 8.4.6.1. Germany: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.7. Cell Therapy Technologies Market - Italy
- 8.4.7.1. Italy: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.8. Cell Therapy Technologies Market - Spain
- 8.4.8.1. Spain: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.9. Cell Therapy Technologies Market - Netherlands
- 8.4.9.1. Netherlands: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.10. Cell Therapy Technologies Market - Russia
- 8.4.10.1. Russia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.4.11. Cell Therapy Technologies Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5. Cell Therapy Technologies Market - Asia Pacific
- 8.5.1. Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.4. Cell Therapy Technologies Market - China
- 8.5.4.1. China: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.4.3. China: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.5. Cell Therapy Technologies Market - India
- 8.5.5.1. India: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.5.3. India: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.6. Cell Therapy Technologies Market - Malaysia
- 8.5.6.1. Malaysia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.7. Cell Therapy Technologies Market - Japan
- 8.5.7.1. Japan: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.8. Cell Therapy Technologies Market - Indonesia
- 8.5.8.1. Indonesia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.9. Cell Therapy Technologies Market - South Korea
- 8.5.9.1. South Korea: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.10. Cell Therapy Technologies Market - Australia
- 8.5.10.1. Australia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.5.11. Cell Therapy Technologies Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.6. Cell Therapy Technologies Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.6.4. Cell Therapy Technologies Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.6.5. Cell Therapy Technologies Market - UAE
- 8.6.5.1. UAE: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.6.6. Cell Therapy Technologies Market - Israel
- 8.6.6.1. Israel: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.6.7. Cell Therapy Technologies Market - South Africa
- 8.6.7.1. South Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.6.8. Cell Therapy Technologies Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.7. Cell Therapy Technologies Market - Latin America
- 8.7.1. Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.7.4. Cell Therapy Technologies Market - Mexico
- 8.7.4.1. Mexico: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.7.5. Cell Therapy Technologies Market - Brazil
- 8.7.5.1. Brazil: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.7.6. Cell Therapy Technologies Market - Argentina
- 8.7.6.1. Argentina: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
- 8.7.7. Cell Therapy Technologies Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Agilent Technologies Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Avantor, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Becton, Dickinson and Company (BD)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bio-Techne Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Corning Incorporated
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Danaher Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Fresenius SE & Co. KGaA
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Lonza Group AG
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Merck KGaA
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Sartorius AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Terumo Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Thermo Fisher Scientific Inc
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
